RADIATION THERAPY ONCOLOGY GROUP
RTOG 0619
A RANDOMIZED PHASE II TRIAL OF CHEMORADIOTHERAPY VERSUS CHEMORADIOTHERAPY AND VANDETANIB FOR HIGH-RISK POSTOPERATIVE ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
RTOG 0619
A RANDOMIZED PHASE II TRIAL OF CHEMORADIOTHERAPY VERSUS CHEMORADIOTHERAPY AND VANDETANIB FOR HIGH-RISK POSTOPERATIVE ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Protocol Participation Information
- Credentialing
- Credentialing Requirements
- Facility Questionnaire: Part I is required for this protocol.
- Dry Run Guidelines (same as RTOG 0522)
- How to Participate
- Digital Data Submission Procedures
- Digital Data Submission Information Form
- Submission Check list
- ATC Compliant Treatment Planning Systems
- Structure Names
- Neck Node Atlas
- Protocol Text (http://www.rtog.org)
Back to protocols
